Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Verhelst

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cytokine & Growth Factor Reviews|November 29, 2011
Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination eventsKelly Verhelst, Isabelle Carpentier, Rudi Beyaert
Cell Death and Differentiation|April 1, 2017
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so differentMarie Lork, Kelly Verhelst, Rudi Beyaert
EMBO Reports|June 1, 2014
A20: attractive without showing cleavageKelly Verhelst, Geert van Loo, Rudi Beyaert
Trends in Biochemical Sciences|May 7, 2011
TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyondLynn Verstrepen, Kelly Verhelst, Isabelle Carpentier, et al.
Biochemical Pharmacology|January 22, 2013
IκB kinase ε (IKKε): a therapeutic target in inflammation and cancerKelly Verhelst, Lynn Verstrepen, Isabelle Carpentier, et al.
Biochemical Pharmacology|May 26, 2009
ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signalingLynn Verstrepen, Isabelle Carpentier, Kelly Verhelst, et al.
Biochemical Pharmacology|July 27, 2011
Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do notKelly Verhelst, Lynn Verstrepen, Isabelle Carpentier, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulationKelly Verhelst, Lynn Verstrepen, Beatrice Coornaert, et al.
Immunological Reviews|June 19, 2015
The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitinationLynn Elton, Isabelle Carpentier, Kelly Verhelst, et al.
Biochemical and Biophysical Research Communications|August 12, 2015
XEDAR activates the non-canonical NF-κB pathwayKelly Verhelst, Sandra Gardam, Alice Borghi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cytokine & Growth Factor Reviews|November 29, 2011
Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination eventsKelly Verhelst, Isabelle Carpentier, Rudi Beyaert
Cell Death and Differentiation|April 1, 2017
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so differentMarie Lork, Kelly Verhelst, Rudi Beyaert
EMBO Reports|June 1, 2014
A20: attractive without showing cleavageKelly Verhelst, Geert van Loo, Rudi Beyaert
Trends in Biochemical Sciences|May 7, 2011
TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyondLynn Verstrepen, Kelly Verhelst, Isabelle Carpentier, et al.
Biochemical Pharmacology|January 22, 2013
IκB kinase ε (IKKε): a therapeutic target in inflammation and cancerKelly Verhelst, Lynn Verstrepen, Isabelle Carpentier, et al.
Biochemical Pharmacology|May 26, 2009
ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signalingLynn Verstrepen, Isabelle Carpentier, Kelly Verhelst, et al.
Biochemical Pharmacology|July 27, 2011
Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do notKelly Verhelst, Lynn Verstrepen, Isabelle Carpentier, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulationKelly Verhelst, Lynn Verstrepen, Beatrice Coornaert, et al.
Immunological Reviews|June 19, 2015
The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitinationLynn Elton, Isabelle Carpentier, Kelly Verhelst, et al.
Biochemical and Biophysical Research Communications|August 12, 2015
XEDAR activates the non-canonical NF-κB pathwayKelly Verhelst, Sandra Gardam, Alice Borghi, et al.
Pageof 2